Lung cancer is a particularly challenging form of cancer. It often strikes unexpectedly and aggressively with little warning, ...

Allison Ciaccio had a respiratory illness that wouldn't go away. Repeated follow-ups found Stage I lung cancer.

The companies were showcasing lung cancer data from their two rival blockbuster ... tumour mutation burden (TMB) in its latest studies. The combination tripled progression-free survival at one ...

Scientists have created a new low-cost, fast response sensor to detect lung cancer biomarkers, paving the way for the ...

but it finally has a positive result in lung cancer. In the POSEIDON trial, triple therapy with PD-L1 inhibitor Imfinzi (durvalumab), CTLA4 inhibitor tremelimumab and a choice of chemotherapy ...

Researchers at the Johns Hopkins Kimmel Cancer Center and Bloomberg~Kimmel Institute for Cancer Immunotherapy have developed a computer model to help scientists identify tumor-fighting immune cells in ...

The assay will identify patients with six cancer types, namely solid tumours, breast cancer, colorectal cancer (CRC), ...

Nelmastobart (hSTC810) combined with capecitabine therapy in metastatic colorectal cancer with resistance or intolerance to oxaliplatin and irinotecan-based chemotherapy: A phase 1b clinical trial.